Accéder au contenu
Merck

Vitamin B12 deficiency: the great masquerader.

Pediatric blood & cancer (2013-10-12)
Sarah Dobrozsi, Veronica H Flood, Julie Panepinto, J Paul Scott, Amanda Brandow
RÉSUMÉ

Vitamin B12 deficiency is rare in children, with nonspecific symptoms including failure to thrive, vomiting, anorexia, and neurologic changes with or without hematologic disturbances. The neuropathy can be severe and irreversible. We report four cases of children with B12 deficiency secondary to adult type pernicious anemia, a presumed transport protein abnormality, and a metabolic defect. All demonstrated neurologic compromise that improved after initiation of B12 therapy. Hematologic manifestations may be preceded by constitutional, gastrointestinal, or neurologic changes, and must raise concern for B12 deficiency. Therapy should be initiated promptly in this setting to prevent irreversible neuropathy.

MATÉRIAUX
Numéro du produit
Marque
Description du produit

Sigma-Aldrich
Vitamine B12, ≥98%
Supelco
Vitamine B12, pharmaceutical secondary standard, certified reference material
Sigma-Aldrich
Vitamine B12, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥98%
Supelco
Cyanocobalamin (B12), analytical standard
Supelco
Vitamine B12, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
Vitamine B12, meets USP testing specifications
Vitamine B12, European Pharmacopoeia (EP) Reference Standard